HealthLynked Corporation (QB) (HLYK) Quote

These guys have zero knowledge and experience of what drives liquidity and valuations. Moving on to. far greener pastures. Dead money here for years to come.

Of course nothing but real news is going to move this stock upward plus the ability to keep it from falling back but I did figure that Dr. Dent would have had a "Proactive video" by now introducing the new CFO.

It appears the computer running these trades can't even keep the stock price from falling.

Personally glad the ''BIG GAME HUNTER" is hunting somewhere's else now.

This stock is down over 95% from it's high. No one here is making any money. Good riddance he's gone. It was his forward statements about joining the Nasdaq is why I stayed in this at much higher prices like in the $.70's. The fact that this is trading at .06 and nobody wants it, is a tribute of poor leadership.

I am still here and keep hoping but that's a piss poor way to invest.

Just my opinion.

weo

CFO - George O'Leary, thank you for your support and professionalism within the HealthLynked Family.

George O'Leary tendered his resignation as Chief Financial Officer of HealthLynked Corp., a Nevada corporation (the “Company”) effective April 4, 2024.

HealthLynked Announces Fourth Quarter and Full Year 2023 Results Highlighted by 70% Reduction in Net Loss for Q4



NAPLES, FL -- April 2, 2024 -- InvestorsHub NewsWire -- HealthLynked Corp. (OTCQB: HLYK), a leader in healthcare networking and technological innovation, announced its financial results for the fourth quarter and full year ended December 31, 2023. With strategic advancements and its focus on core healthcare technologies and networking capabilities, HealthLynked achieved a significant 70% reduction in net loss for the fourth quarter, highlighting a period of fiscal management and strategic positioning for future growth.

Full Year 2023 Financial Results

Strategic Focus and Technological Innovations Pave the Way for an Optimistic Outlook: HealthLynked reported a modest 2% revenue decrease to $5.72 million, attributed in part to the retirement of, and contracts ending for, certain key physicians and the onboarding phase of new physicians at several clinical sites. Despite these temporary staffing adjustments, HealthLynked's strategic direction and the release of the new pay app version 3.2.0 quartering first quarter 2024 create a new opportunity for core revenue growth. The forthcoming integration of ARI, our AI-driven healthcare guide, into the newly released HealthLynked app represents a pivotal stride towards leveraging technology to enhance our healthcare network's effectiveness.

Operational Efficiency through Key Enhancements: Optimization of operational expenses led to a 52% cut in operational losses, demonstrating HealthLynked's commitment to financial stewardship and operational efficiency. Strategic restructuring resulted in a 19% reduction in operating expenses. Exclusive of impairment charges, the operational loss declined by 35%. Our targeted efforts to refine operations and strategically invest in our healthcare network and technology capabilities have poised us for sustainable growth and a solid financial footing.

Solid Financial Health from Strategic Divestiture: The strategic sale of ACO Health Partners, alongside the gains realized from this initiative, contributed significantly to our financial restructuring, bringing in $3.76 million. This move underscores our focus on our core competencies in healthcare networking and technological innovation, significantly bolstering our liquidity and financial resilience.

Dramatic Net Loss Reduction: A significant decrease in net loss to $1.01 million in 2023 from $8.82 million in 2022 illustrates the positive impact of our strategic divestitures, operational efficiencies, and profit stabilization despite temporary staffing changes. The integration of cutting-edge technologies and our strategic focus creates a path forward of continued growth and operational improvement.

Fourth Quarter 2023 Financial Results

Revenue Commitment to Core Technologies Following Staffing Transition: Revenue declined to $0.93 million in Q4 2023, primarily as a result of temporary physician staffing adjustments along with associated physician pay. This new baseline in cost prepares HLYK for improved profitability in the second half of 2024 with an expected operating profit by the end of the fiscal year. The introduction of our new pay app version 3.2.0 is indicative of our focus on achieving profitability and technological leadership in the healthcare sector by the end of 2024.

Strategic Initiatives Lead to Reduced Operating Loss: A 73% reduction in operating loss to $1.11 million in Q4 2023, demonstrating our resilience and strategic focus during a period of staffing transition. Exclusive of a $2.75 million Q4 2022 impairment charge, the operating loss decline was 21%. This underscores our commitment to operational efficiency and financial health.

Substantial Improvement to Net Loss Reflects Strategic Strength: A 70% reduction in net loss to $1.29 million in Q4 2023, underscores the effectiveness of our strategic initiatives, showcasing our adaptability and commitment to navigating towards long-term financial sustainability and growth.

Executive Insights

Dr. Michael Dent, CEO of HealthLynked, stated, "The recent launch of our pay app version 3.2.1 and the forthcoming integration of ARI mark significant milestones in our mission to transform healthcare delivery and drive additional revenues. Despite temporary staffing transitions, our focus on our core healthcare network and technological innovations positions us for substantial growth and profitability. We continue to grow our user base while integrating technology that improves patient care and the efficient exchange of medical information between doctors and patients."

George O'Leary, CFO of HealthLynked, added, "Our strategic decisions throughout 2023 have laid a solid groundwork for growth. By concentrating on our core technologies and healthcare network, HealthLynked is poised to advance more profitably, continuing to innovate and lead in the healthcare sector."

HealthLynked's dedication to driving healthcare innovation through strategic focus and technological advancement remains strong. We are grateful for the continued support of our investors and stakeholders as we navigate these transitions and stride towards a future marked by growth, innovation, and enhanced healthcare outcomes.

About HealthLynked

HealthLynked Corp. is dedicated to improving global community health. Our mission unfolds in two pivotal goals: First, to transform healthcare into a system marked by enhanced efficiency and improved care for all, leveraging cutting-edge technology and connectivity. Second, to forge a patient-centric network that not only places patients at the heart of their healthcare journey but also mobilizes their participation to accelerate medical discoveries and the development of cures for diseases that impact humanity. This pioneering model empowers individuals with unparalleled access to and control over their medical information, fostering a collaborative environment where every patient contribution can spearhead breakthroughs in health and wellness. Through these concerted efforts, we aim to secure a healthier future for generations to come.

At the heart of our endeavors is the HealthLynked Network, a sophisticated, cloud-based platform designed to facilitate the seamless exchange of medical information among patients and healthcare providers. By centralizing and securing medical data — including medications, allergies, past surgeries, and personal health records — our members are empowered to take an active role in managing their healthcare with unparalleled ease and efficiency.

HealthLynked is a beacon for healthcare providers, offering an ecosystem that enhances patient care through improved communication and access to critical health information. Our network fosters an environment where providers can gain valuable insights into practice operations, enhancing patient compliance and optimizing scheduling. Providers are encouraged to join our network by claiming their profiles, thereby accessing HealthLynked's suite of marketing tools designed to foster meaningful engagements with patients.

A cornerstone of our philosophy is the ethical management of healthcare data. HealthLynked does not sell any healthcare data, ensuring the privacy and security of our members' information at all times.

We invite you to join us in this journey towards a healthier future. Download the HealthLynked app today, available on both Android and Apple devices, and take the first step in taking control of your healthcare.

For more information about HealthLynked Corp., including details on how to become a part of our growing community, please visit our website at www.healthlynked.com.

Download for Apple

Download for Android

Together, we are paving the way for a future where healthcare is more accessible, efficient, and interconnected than ever before. Welcome to the next generation of healthcare. Welcome to HealthLynked.

For more about HealthLynked Corp., please visit www.healthlynked.com. Stay connected with HealthLynked on Twitter, Facebook, Instagram, and LinkedIn.



Forward-Looking Statements & Risk Factors

Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, including as a result of any acquisitions, performance, or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the "Risk Factors" section of our most recent Annual Report on Form 10-K and in other filings we have made with the U.S. Securities and Exchange Commission. These reports are publicly available at www.sec.gov.



For further information, please contact:

HealthLynked Corp
Public Relations
Email: pr@healthlynked.com


Investor Relations:
Michael Paisan, Director of Investor Relations
Phone: 1-800-928-7144, ext 123

Website: www.healthlynked.com


HealthLynked Corp.

Selected Consolidated Financial Data

Year and Quarter Ended December 31, 2023, and 2022
https://ih.advfn.com/stock-market/USOTC/healthlynked-qb-HLYK/stock-news/93589555/healthlynked-announces-fourth-quarter-and-full-year

Thanks for that ,wasn't expecting any positives but only 22M is encouraging

Here is the 10-K https://www.sec.gov/ix?doc=/Archives/edgar/data/1680139/000121390024028696/ea0201745-10k_health.htm

OS only grew 22 million more shares since last 10-K.

We don't know what transpired if anything between George and Michael but since George is still under contract days before separation I would think we will see a 10-K today followed by some type of earnings report. I would think earnings will be flat only because the deep scratching the company is doing to push forward.

With the Shareholders letter coupled with recent changes (positions) I would think Dent is putting everything he can into this to try and make it work so I don't expect a good earnings report but cool if we do.

Looks like he held on to the PR, did they even have a CTO prior to Hall?. Anyone know if earnings come out tomorrow?

In the following press release dated 12/13/23 you can see that Chris Hall was already our CTO. It appears Dr. Dent is trying to push old news.
https://ih.advfn.com/stock-market/USOTC/healthlynked-qb-HLYK/stock-news/92798442/healthlynked-unveils-advanced-search-functionality


Well I guess he still isn't worth a salary as there were no recent 8-K to reflect wage information. I'm starting to wonder just when Chris actually became CTO did I miss a filing prior to 12/13/23 referencing Chris?

Latest PR.....3/19/24 https://ih.advfn.com/stock-market/USOTC/healthlynked-qb-HLYK/stock-news/93513560/healthlynked-corp-announces-chris-hall-as-new-chief So is Chris still a junior CTO or what?

Sorry wrong board

Philip frost

I thought for sure that appointing Mr. Chris Hall as an Officer of the company would warrant a salary which would also call for an 8-K to be filed. With all the statements that were mentioned by Dr. Dent yet Chris isn't worth a salary?.... or was this just a fluffy press release.... maybe a Proactive introduction video will be next?

HealthLynked Announces Exciting New Update with HealthLynked 3.2.0 - Transforming Patient-Care Through Innovation

Naples, FL -- March 26, 2024 -- InvestorsHub NewsWire -- HealthLynked Corp. (OTCQB: HLYK) , a pioneering healthcare network focused on enhancing the efficiency and quality of patient care, is thrilled to announce the launch of its latest app update, HealthLynked 3.2.0. This significant update introduces a suite of new features and improvements designed to revolutionize the way individuals and families manage their healthcare journey.

What's New in HealthLynked 3.2.0?

New Monthly Subscription Plan: Responding to user feedback, HealthLynked introduces a flexible Monthly plan, allowing users to access premium features with greater ease.
First Concierge Appointment Free: New and existing users can enjoy their first Concierge appointment through the app at no cost, providing a risk-free way to experience the benefits of HealthLynked.
Unlimited Storage for Premium Members: Premium users will now benefit from unlimited storage, ensuring that all your health data is securely stored and easily accessible.
Family Member Profiles: Users can now connect with family members to their account, making it easier than ever to manage the health of loved ones.
Health Journal Organization: Keep track of your health journey with an organized health journal, making it easier to monitor progress and health patterns.
Child Profile Creation: The app now allows for the creation of child profiles for individuals under 18, ensuring that the whole family's health is managed seamlessly.
Simplified Doctor Appointments: Booking doctor appointments has been made simpler, with an intuitive interface that makes managing your health care a breeze.
Performance Improvements: Ensuring a smooth and reliable user experience, the latest version includes numerous performance enhancements.

A New Approach to Membership

In a shift from the traditional 30-day free trial requiring a credit card, HealthLynked has introduced a free version of the app. Users can upgrade to a paid membership at any time, choosing between two flexible options: a $12/month plan that can be canceled at any time, or an annual plan at $120, offering a 17% discount off the monthly rate. This new structure ensures that everyone has access to high-quality healthcare management tools, with the option to upgrade for additional premium features like unlimited data storage and the ability to connect to unlimited family members.

Innovation at the Heart of HealthLynked

Chris Hall, Chief Technology Officer at HealthLynked, shares his excitement about the latest release: "We are constantly pushing the boundaries of what's possible in healthcare technology. With HealthLynked 3.2.0, we've taken a significant leap forward, not only in terms of the app's functionality but also in how we engage with our users. Moving to a free version of the app underscores our commitment to accessibility, ensuring that more people can benefit from our platform without upfront costs. It's about putting the power of health management back in the hands of individuals and families, in the most user-friendly way possible."

Dedicated to Innovation and Accessibility

"HealthLynked is committed to improving healthcare access and management for everyone," said Dr. Michael Dent, CEO of HealthLynked. "With the launch of HealthLynked 3.2.0, we're not just introducing new features; we're transforming the way patients and doctors connect and manage health. Our new membership model is a testament to our commitment to making healthcare more accessible and flexible for our users."

Availability

HealthLynked 3.2.0 is available now. To learn more about HealthLynked and to download the app, visit HealthLynked's website or find it in your app store.

About HealthLynked

HealthLynked Corp. is dedicated to improving global community health. Our mission unfolds in two pivotal goals: First, to transform healthcare into a system marked by enhanced efficiency and improved care for all, leveraging cutting-edge technology and connectivity. Second, to forge a patient-centric network that not only places patients at the heart of their healthcare journey but also mobilizes their participation to accelerate medical discoveries and the development of cures for diseases that impact humanity. This pioneering model empowers individuals with unparalleled access to and control over their medical information, fostering a collaborative environment where every patient contribution can spearhead breakthroughs in health and wellness. Through these concerted efforts, we aim to secure a healthier future for generations to come.

At the heart of our endeavors is the HealthLynked Network, a sophisticated, cloud-based platform designed to facilitate the seamless exchange of medical information among patients and healthcare providers. By centralizing and securing medical data — including medications, allergies, past surgeries, and personal health records — our members are empowered to take an active role in managing their healthcare with unparalleled ease and efficiency.

HealthLynked is a beacon for healthcare providers, offering an ecosystem that enhances patient care through improved communication and access to critical health information. Our network fosters an environment where providers can gain valuable insights into practice operations, enhancing patient compliance and optimizing scheduling. Providers are encouraged to join our network by claiming their profiles, thereby accessing HealthLynked’s suite of marketing tools designed to foster meaningful engagements with patients.

A cornerstone of our philosophy is the ethical management of healthcare data. HealthLynked does not sell any healthcare data, ensuring the privacy and security of our members’ information at all times.

We invite you to join us in this journey towards a healthier future. Download the HealthLynked app today, available on both Android and Apple devices, and take the first step in taking control of your healthcare.

For more information about HealthLynked Corp., including details on how to become a part of our growing community, please visit our website at www.healthlynked.com.

Download for Apple

Download for Android

Together, we are paving the way for a future where healthcare is more accessible, efficient, and interconnected than ever before. Welcome to the next generation of healthcare. Welcome to HealthLynked.

For more about HealthLynked Corp., please visit www.healthlynked.com. Stay connected with HealthLynked on Twitter, Facebook, Instagram, and LinkedIn.

For further information, please contact:

HealthLynked Corp
Public Relations
Email: pr@healthlynked.com


Investor Relations:
Michael Paisan, Director of Investor Relations
Phone: 1-800-928-7144, ext 123

Website: www.healthlynked.com

As for PBA to complete a ("IPO") by August 1, 2024, it sure doesn't look like that will happen so no additional incoming from them.

Healthlynked - Announces Chris Hall CTO

https://investors.healthlynked.com/presstype/healthlynked-corp-announces-chris-hall-as-new-chief-technology-officer/

I hope he's not Dan Hall's brother as it would lead to less credibilty IMO. But then again, it's an Arthrex connection and might portend to something of value down the road. The plot thickens..

It would seem to me that we will see a 8-k either today or Monday referencing Christ Hall and his position as CTO. I say this with respects that if my CTO is an officer of my company he will be paid a salary plus many other benefits.

I also feel will will see a PROACTIVE video in coming weeks introducing our two new officers of HLYK.

As for a future RS? I look at Dents history and actions way back other than that I have no clue however, I look at "fully diluted shares" and how quickly they might add up referencing several possible NASDAQ listing requirements. I think next weeks 10-k plus our future Q1 will enlighten us in several areas.

I like the idea and using the newest technologies yet I still don't understand how Mr. Rosal will be able to explain (define) for easier understanding to us however, maybe it is geared more for potential Institutional investments which I could understand why Dr. Dent is moving in that direction.

We may never know what really happen, separation of Mr. O' Leary from HLYK or rather from Dr. Dent as they had been together for years. Might just be a change needed like when I look at my first of three wives 🤣 ...also I gather Chris is Dan Hall's brother

If they were trying to get the SP up for Naz requirements at .05 now it would be somewhere north of 50-1 RS. Dent has stated he would not do that, but that was a few years ago. I don't see him in rush to uplist for the sake of being on a major exchange, rather staying on the OTC and growing it organically then applying. The float is only 150M ( last time i checked) which isn't all that huge, if they execute at a high level that size float will shrink dramatically . Lets' hope they don't perform an RS,it will be eviscerated immediately thereafter by shorts.

A question to all , what would be a reverse split number ? 1 for 25, 1 for 50 ???

It is clear with Dr. Dent that it is far more than money that he really wants to make a difference in various medical areas. We also know he is the type of man to constantly make changes and adapts kinda like a Tom Brandy style.

Yes looking at his past I still worry and a RS in our future but believe we have the right management team so far as they all seem to be brave fearless professionals that see something that many of us may not see yet?

I do know that Mr. Rosal had a new house built about 1 hours drive from Dr. Dents place in 2022 if I recall.

As for Chris Hall now he fits what I needed to see involving patents right from the get go but he also has massive reach involving our life cycle so in time we should smile. You gotta figure we now our management is not some scam which is at least 80% of these damn stocks but like I said I do fear that RS in our future.

I also see Dr. touched on India again plus the style of management insight that Chris Hall brings is super cool. He allows the workers and other professional loose to do their thing instead of crippling the worker/professional. I see India (which is huge) growing our business like wildfire. Time will tell.

Why do guys like Rosal and Hall leave very high paying tech behemoths to take a massive pay cut and work for a nothing comany? Maybe they see a chance to do something very special here.

HealthLynked Corp Announces Chris Hall as New Chief Technology Officer
Naples, FL -- March 19, 2024 -- InvestorsHub NewsWire -- HealthLynked Corp (OTCQB: HLYK), a leader in healthcare technology innovation, is excited to announce Chris Hall as the new Chief Technology Officer (CTO). Chris brings a wealth of experience in technology and product development, marked by his leadership in launching over 100 products and managing diverse, global teams. His strategic foresight and technological prowess have been successfully demonstrated across various roles, making significant impacts in product development and commercialization.

Before his appointment at HealthLynked, Chris worked at Battelle as a Sr. Product Portfolio Manager and at HF Scientific as the Manager of New Product Development after spending nearly two decades working for Siemens and their affiliates developing cutting edge technologies for the global market. His leadership in these roles led to substantial sales growth and the adoption of agile methodologies, enhancing product development processes and operational efficiency. His demonstrated success in these endeavors should have a positive impact on HealthLynked's network growth strategy in the years to come.

Notably, Chris has been responsible for over a dozen patents across multiple technologies, showcasing his inventive spirit and contribution to technological advancement in various sectors.

Chris holds an MBA from Western Governor's University and a B.Sc. in Chemical Engineering from Colorado State University. He is also a certified Project Management Professional (PMP), with expertise in regulatory compliance, budgeting, financial analysis, and agile project management.

In his role at HealthLynked, Chris will oversee the company's technology strategy, focusing on the development and coordination of innovative healthcare solutions. He will manage and synchronize the development processes between HealthLynked's USA and Indian development teams, crucial for the seamless execution of crucial projects like ARI, HealthLynked's personalized AI healthcare guide. ARI aims to revolutionize patient care by offering tailored health guidance that will be a major factor in distinguishing Healthlynked's app in the marketplace.

Dr. Michael Dent, CEO of HealthLynked, expressed his enthusiasm about Chris's appointment: "Chris joining us marks a transformative step forward. His leadership in managing our global teams, especially in the development of innovative projects like ARI, is invaluable. His track record of securing patents and pushing technological boundaries aligns perfectly with our mission."

Chris Hall commented on his new role: "I'm truly impressed by HealthLynked's vision to enhance healthcare globally, focusing on efficiency and patient-centered care. It's an honor to be part of a team that not only values innovation but actively works to make a real difference. I'm eager to leverage my experience and the patents I've been involved with to contribute to our mission of transforming healthcare through advanced technology."

Chris Hall's appointment reflects HealthLynked's commitment to excellence and innovation in healthcare technology. The company looks forward to the advancements and improvements Chris will bring, aiming to enhance healthcare delivery and patient outcomes worldwide.

About HealthLynked

HealthLynked Corp. is dedicated to enhancing healthcare by facilitating the efficient exchange of medical information between patients and providers. Our cloud based HealthLynked Network empowers members to actively manage their healthcare, providing a centralized and secure location for their medical data, including medications, allergies, past surgeries, and personal health records.

Healthcare providers in our network benefit from improved patient care and key insights into their practice operations. Additionally, our preferred providers can leverage HealthLynked's marketing tools to engage both patients, ensuring better patient compliance and optimized scheduling. To avail these services, providers need to claim their profiles and complete the necessary steps to become an in-network provider.

For more about HealthLynked Corp., please visit www.healthlynked.com. Stay connected with HealthLynked on Facebook, Twitter, Instagram, and LinkedIn.

Forward-Looking Statements & Risk Factors

This press release contains forward-looking statements that are not based on historical facts. These statements, as defined by the Private Securities Litigation Reform Act of 1995, may differ from actual results, performance, or achievements. Forward-looking statements involve inherent risks and uncertainties. We advise against placing undue reliance on these statements, which are current only as of the date of this press release.

We are not obligated to publicly update any forward-looking statements unless required by law. Any updates should not be interpreted as an indication of additional updates on the same or other topics. For a detailed understanding of the risks and uncertainties related to our operations, please refer to the "Risk Factors" in our latest Annual Report on Form 10-K and other filings with the U.S. Securities and Exchange Commission, available at www.sec.gov.

HLYK Contact:

Mike Paisan

Director of Investor Relations

IR@healthlynked.com

+1 (800)-928-7144, ext. 123
https://ih.advfn.com/stock-market/USOTC/healthlynked-qb-HLYK/stock-news/93513560/healthlynked-corp-announces-chris-hall-as-new-chie

CFO Analytics what is it and why should you care?

https://www.teradata.com/blogs/cfo-analytics-what-is-it-and-why-should-you-care

Press release dated 3-13-24 New CFO
https://ih.advfn.com/stock-market/USOTC/healthlynked-qb-HLYK/stock-news/93480924/healthlynked-welcomes-david-rosal-as-new-chief-fin


SEC filing
https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/1680139/000121390024022598/ea0201822-8k_health.htm


David Rosal.........
https://www.teradata.com/blogs/cfo-analytics-cfo-of-the-future

David Rosal - Consultant at Teradata
Here Dave discusses several areas
https://www.teradata.com/blogs/authors/david-rosal

I don't believe Dr. Dent could start an additional business doing AI but perhaps we can somehow see HLYK working in some type of partnership with one of these corporations??? Anyone have any thoughts?

I have a surgery at 1pm so won't be posting further here for weeks.

Sure AI will be huge and AI stocks will eventually flood the OTC....the hype will be like it was in 1999....back then you could throw a dart at any tech stock with your eyes closed and hit the bulls eye 80 percent of the time.

As for Dr. Dent establishing AI in a huge way with HLYK I sincerely don't see any technical/engineering AI ability in our patent. As I stated before HLYK will need to license another parties patents or we will never amount or capitalize on AI as some here would like. Those words are not hollow by far since reviewing our current patent (as it is written) is clear. I also don't think people understand that just because the application was successful that doesn't mean a patent is iron clad.

We can hope for the best but I gotta tell you Dr. Dent must move in a different direction if possible.

Interesting perspective, i 'm sure he wants you to purchase something but good overview. Wouldn't it be swell if we got in early on this? https://pro.paradigmnewsletters.org/p/aln_wealthwindow_1023/LALN4239/?cake_s1=02_151747222_081dd6dc-3454-41bf-a324-71ad010b828d&h=true

Now if you are looking for the basic "present" businesses that Dent has they can be found here.....


Florida Corporations..........
Naples Women's Center llc
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=MICHAELDENTTDR%20L070000780340&aggregateId=flal-l07000078034-876149d2-a94f-484c-ba1d-204a3dea3bfd&searchTerm=michael%20dent&listNameOrder=MICHAELDENTON%208242066

HLYK Florida llc
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=DENTMICHAELDR%20L180001588191&aggregateId=flal-l18000158819-166b243d-a1a5-455e-8984-3a83f9d678c4&searchTerm=Dent%20Michael&listNameOrder=DENTMICHAEL%20L130001672181

Forever Movie llc
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=DENTMICHAEL%20L220004856370&aggregateId=flal-l22000485637-901fadc0-2a57-4de1-885a-69660e3a38e4&searchTerm=Dent%20Michael&listNameOrder=DENTMICHAEL%20L130001672181

HealthLynked Corporation
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=DENTMICHAELMD%20F180000032181&aggregateId=forp-f18000003218-a3ea2964-602e-4ff3-a994-78e6305d5c7b&searchTerm=Dent%20Michael&listNameOrder=DENTMICHAEL%20L130001672181

UJMI llc
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=ForwardList&searchNameOrder=DENTMICHAELT%20L160001646492&aggregateId=flal-l16000164649-0dc90185-f31b-4b91-898a-49616c2366a3&searchTerm=Dent%20Michael&listNameOrder=DENTMICHAELMD%20L040000557180

Now NEVADA Corporations office is a bit more restrictive, no sunshine law like down in Florida but some information is freely available referencing HLYK You can go to Nevada Corporations office and search for Healthlynked or it's EO# 405862014-1
______________________________________________________-

Will post typical USPTO and PACER access/website(s) information today.
_________________________________________________________
BTW....Nevada is also one the two best places to set up a TRUST.

I'm afraid if we don't deal with licensing other corporations patents we just will remain a mom-and-pop business. Our existing patent doesn't have enough integrity to do very much if anything but Dr. Dent remains positive and why not. I see our patent as at least something but nothing more. When Dent did file the provisional prior, you may have heard me discuss the one year time element. Anyways Dent did not complete the provisional within that year, to then file a patent application. At any rate the patent we have is extremely elementary so my hope...excuse me, he had better "continue" that patent and of course file other application depending.

I have a bit of fear now that George will leave after 10-k filing. Dr. Dent seems to be too cautious or works to slow...does he delegate well?

Their typical medical businesses that they have enjoyed for years keeps them busy plus money coming in but for us shareholders?

AI is a big business and Dr. Dent would like that challenge of the AI mix but there are so many players far ahead and that hold real AI and other machine learning patents It is like HLYK trying to enter a Model-A on a Interstate/freeway. We need another player.

Where's the A.I. news, updates or anything wtf?

Adding like hell. Way way oversold

Talk is cheep as they say, so far that's all it's been. He's either clueless, or so confident he thinks the SP will take care of itself. Wish i knew what George does, that could work either way for shareholders, all 20 of us;)

I don 't think the good doctor knows how to create shareholder value. Right now it seems we are on the wing and a prayer program lol. I certainly didn't think we would pull back to these levels after they sent out that letter. Alas, this is the OTC. I am not even looking for much, $.10-$.12 cents and I would think about selling. Very frustrating.

Adding. Super cheap now

Buying!

I sincerely believe the video (yes I rented it) is at least a 4 star rating. As to the information I give that a 5. I noticed I was able to thumbs up the move but to review it and give it a rating it seems that isn't available. I will also state that Dr. Michael Dent doesn't know the words I can't do as he will no matter what it takes he will do so.

I personally don't feel good about our time frame as to where we sit and that might be because of the past hype/run and of course O'Leary leaving. I went to Amazon to rent the movie and click other options and was able to access the movie for $1.99 which if I recall was 24 hours period and reviewed it 3 times.

If you are already invested here perhaps $2 buck might be worth the view.

HealthLynked and CEO Dr. Michael Dent Featured in Health Documentary "Forever: The End of Aging," Now Available for Streaming

NAPLES, FL -- January 24, 2024 -- InvestorsHub NewsWire -- HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on improving healthcare outcomes through technology, proudly announces the release of the health documentary "Forever: The End of Aging" on Prime Video. Directed by Paul Castro, acclaimed writer of the blockbuster movie "August Rush," this groundbreaking film features HealthLynked and its CEO, Dr. Michael Dent, offering a compelling look at the future of healthcare and the revolutionary role of AI and technology in medical advancements.

Joining Dr. Dent is an esteemed lineup of over 15 medical experts, including Dr. David Perlmutter, a five-time New York Times bestselling author recognized for his insights into neurological health and nutrition. The documentary explores cutting-edge healthcare solutions such as gene therapy, medical information exchange, and the transformative potential of AI in healthcare.

"Forever: The End of Aging," aligned with HealthLynked's mission of driving improved outcomes for all healthcare stakeholders, bridges the gap in healthcare through efficient medical information exchange. Dr. Michael Dent's participation in the film underscores HealthLynked's commitment to leveraging advanced technologies, including AI, to enhance patient care and outcomes, positioning the company at the forefront of the healthcare revolution.

Watch the Film: Prime Video US - Forever: The End of Aging
https://www.amazon.com/forever-aging-David-Perlmutter-M-D/dp/B0CQ3283V3/ref=sr_1_4?crid=14VPIVGYL5N04&keywords=forever+the+end+of+aging&qid=1706035167&sprefix=forever+the+end+of+aging%2Caps%2C122&sr=8-4

Prime Video UK - Forever: The End of Aging
https://www.amazon.co.uk/forever-aging-David-Perlmutter-M-D/dp/B0CQ2ZR1T2/ref=sr_1_6?crid=EQYQG65HBO3Q&keywords=forever+the+end+of+aging&qid=1706035917&sprefix=%2Caps%2C136&sr=8-6
About HealthLynked

HealthLynked Corp. is dedicated to enhancing healthcare by facilitating the efficient exchange of medical information between patients and providers. Our cloud based HealthLynked Network empowers members to actively manage their healthcare, providing a centralized and secure location for their medical data, including medications, allergies, past surgeries, and personal health records.

Healthcare providers in our network benefit from improved patient care and key insights into their practice operations. Additionally, our preferred providers can leverage HealthLynked's marketing tools to engage both patients, ensuring better patient compliance and optimized scheduling. To avail these services, providers need to claim their profiles and complete the necessary steps to become an in-network provider.

For more about HealthLynked Corp., please visit www.healthlynked.com. Stay connected with HealthLynked on Facebook, Twitter, Instagram, and LinkedIn.

Forward-Looking Statements & Risk Factors

This press release contains forward-looking statements that are not based on historical facts. These statements, as defined by the Private Securities Litigation Reform Act of 1995, may differ from actual results, performance, or achievements. Forward-looking statements involve inherent risks and uncertainties. We advise against placing undue reliance on these statements, which are current only as of the date of this press release.

We are not obligated to publicly update any forward-looking statements unless required by law. Any updates should not be interpreted as an indication of additional updates on the same or other topics. For a detailed understanding of the risks and uncertainties related to our operations, please refer to the "Risk Factors" in our latest Annual Report on Form 10-K and other filings with the U.S. Securities and Exchange Commission, available at www.sec.gov.

HLYK Contact:

Mike Paisan

Director of Investor Relations

IR@healthlynked.com

+1 (800)-928-7144, ext. 123

https://ih.advfn.com/stock-market/USOTC/healthlynked-qb-HLYK/stock-news/93125988/healthlynked-and-ceo-dr-michael-dent-featured-in

Reference O' Leary; from 10/22 8-k
Now we are only talking 15 months so what happened? George couldn't deliver, plus I believe George indicated (my thoughts) that he wanted to move onto something else yet Dent made him a full time employee, yes did you catch that in the link. Other thoughts are about the need to save money but when Dent basically (as I see it) put George totally in charge of up-listing I believe George told Dent HLYK doesn't stand the chance so as a result of everything they both decided on George leaving. On the other hand which is my left (which isn't my best by far) maybe Dent struck a deal with some other company but I must say why would you cut off your right hand? We also seen Dent become very open and compassionate, at least I feel that way. Anyone have other thoughts about all this?

https://www.sec.gov/Archives/edgar/data/1680139/000121390022064963/ea167311ex10-1_health.htm

Dr. Dent moved NEO share price to around $2 bucks and that was about all. It was Douglas M. VanOort who sent NEO into the stratosphere. O' Leary is going to work long enough to close out (10-K) yearly books.

I am right with you. As far as I am concerned, this dude did nothing but piss people off with his commentary about going to the Nasdaq and then following up with nothing. Good riddance.

Bill Bellicheck, Pete Carroll, and Nick Saban all left long term postions this week, it happens. Who care's if smiling George left, stock is at .07 let's have some damn news.

I am not sure yet but tend to believe the reason why we seen Dr. Dent finally talk to us shareholders and actually show sincere compassion by way of his recent shareholder letter may have resulted of George O' Leary resigning, yes he is resigning. I do know George is jumping into or perhaps finally cranking up a "Horse business" and why not do something you may enjoy or possibly with your family members. Of course we can't blame anyone for resigning period but now I'm really getting concerned for HLYK. As I said many times Dr. Dent will end up with doing as he has forever, and that is carrying on with his medical business with wife, and others. He has done this prior NEO and will do so with or without HLYK.

Here is the latest 8-K submitted today 1-11-24 https://www.sec.gov/ix?doc=/Archives/edgar/data/0001680139/000121390024002970/ea191491-8k_healthlynked.htm

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation of George O'Leary

On January 5, 2024, George O'Leary tendered his resignation as Chief Financial Officer of HealthLynked Corp., a Nevada corporation (the “Company”) effective April 4, 2024. Mr. O’Leary's resignation is not a result of any disagreement between himself and the Company, its management, the Company’s Board of Directors (the “Board”) or any committee of the Board. Mr. O'Leary will continue to serve the Company as a member of the Board. The Company appreciates Mr. O'Leary’s diligent service as Chief Financial Officer and looks forward to his continued directorship.

Healthlink going to explode and ramos going to go to tampa and buy protein pancakes and eat them off of Bendzik

I am only a layman (seriously) but will state clearly that A.I.- MACHINE LEARNING has been my investment and studies since 2003. I will say Dent has missed the A.I. but can pay someone else licensing fees and during the growth of our company have Inventors modify patents and continue into the next phases of growth within the patent technologies and growth of the company. Dr. Dent may not have the knowledge nor the know-how directly but when you are a professional as he is he will find the people that can-do if he can't do.

I like his (Dr.Dents) personality as he is now blossoming - maybe his wife final said %^%^(%(...hey, who knows? 😎

Dr. Dent fully knows where the train is and how to get there but it doesn't mean that is his top priority meaning he could be far too caring and the company aspects might take way too long to fully develop yet he is running the company as he sees fit not as other investors or as I want. We have great management but it doesn't mean this company will ever fly like an Eagle but we know it will fly and don't need to worry about management like we do with so many other Penny stocks.

I'd like to see Dent put some more skin in the game with another few million out of his pocket to fund development of the A.I. protocol. If he has to wait for company revenue it will take much longer and might miss the train. This is a pardigm shift in tech and the last will get the least.

A.I. technology yes but Dr. Dent will need to license from some other company or pay out big time to have a A.I patent Inventor help him. Also there are roughly 100,000 A.I. patents worldwide so it would pay us to license from someone. I say this for many reasons but mainly the time element, Dr. Dents short comings involving patent writing, I didn't say engineering but the wording (enough about this for now). If you license patent usage you are generally not stepping on eggs waiting for all kinds of legals involving other patents crossing over other Inventors or other corporations. At this stage our patent would not be challenged by two other inventors but as our patent sits it must be continued and evolve into another patent to gain greater scope and engineering. This isn't important right now but Dr. Dent must be aware of this. I explained about our patent prior; when the company first said they have a patent pending and I couldn't pull anything other than trademarks over a period of 1.5-2 years I knew he didn't follow through with our patent application. Now that the patent application was filed we could see it, you can dig into the filing aspects and see when Dr. Dent first filed for a provisional that protects you for 1 year but before that year is up you must produce your patent application writings. Dent failed but within 5 days after that provisional was scrapped he started again. When we heard/seen the actual application you are able to dig into the history to see what the USPTO refused in each patent application. It is very important to understand that just because the USPTO gives you a patent the patent owner doesn't know if it will stand a challenge involving PTAB due to patent infringement The USPTO tries to do their best in issuing but the oversight is massive when considering all the technical BS plus the politics. So, this is one reason why Dent should consider paying a license fee to someone who has everything intact rock solid that their patents have stood the time. It is important to have the money when some of these issue in a patent war with someone could take 10 plus years to resolve. I will say though since we know how Dent operates and know of his professional business skills I sense that he would be more than willing to work on resolving any patent issues with other corporations. In other words he isn't a greedy man he just wants to have his own space to present to the world something in the medical world to help many others.

Now do know Dr. Dent picked one of the largest corporation in the world to engineer our patent but some of the wordings, (strike the word cell phone yet the device is a cell phone) might comeback and bite us years down the road but maybe not.

It will be cool to see the next patent application....I also have hope that the company will list to application numbers for some people that like digging into this area.

Take my words lightly but is always straight off the cuff

Dunno..it's been under a dime all year, not much to write off if you've been a bagholder for years on this like me. However, being the habitual gambler on OTC's, I will continue to hold and do think 24 WILL be the year they get it going. I really found Dent's letter to be profound, and if they can get some traction there's no way it won't be trading at multiples of todays SP in the next six months, maybe much sooner than that. A.I. is goiing to be the buzzword in 24 IMO, and Dent has been praising it's virtues for years now. If they can get out front with their A.I. patent portfolio that creates value as well as earnings, according to the letter they have several in the pipe.